Mr. Sami Sagol visits the SCRM
Prominent philanthropist Mr. Sami Sagol, whose generous support made the Sagol Center for Regenerative Medicine (SCRM) possible, recently visited the Center at the Gray Faculty of Medical and Health Sciences, Tel Aviv University. During his visit, he met with PhD students, researchers, and staff whose work is made possible through his funding. These meetings included presentations showcasing ongoing studies in regenerative medicine, tissue engineering, longevity, and personalized medicine, and covered the Center’s vision for future research and continued growth. The visit underscored Sagol’s commitment to accelerating cutting‑edge biomedical innovation and nurturing the next generation of clinician-scientists in Israel.
Left-to-right: Mr. Amos Elad (Vice President for Resource Development, TAU), Mr. Ido Rosen (MD-PhD student), Dr. Tal Golan (Physician, SCRM researcher), Dr. Michael Namestnikov (MD-PhD student), Dr. Keren Shternhall Ron (SCRM administrator), Dr. Tomer Itkin (SCRM researcher), Prof. Benjamin Dekel (SCRM director), Prof. Rina Arbesfeld (Researcher at Gray Faculty of Medical and Health Sciences), Mr. Sami Sagol, Prof. Ariel Porat (TAU president), Dr. Dekel Rosenfeld (SCRM researcher), Mr. Noam Rattner (MD-PhD student).
As part of the visit, Mr. Sagol received the SCRM brochure, which outlines the Center’s vision, leadership team, and research community, as well as details of its grant programs, innovative projects, and educational initiatives. Highlights include collaborative research on hearing loss, colon cancer, ALS, liver regeneration, rare kidney diseases, and nerve repair; training programs for MD-PhD students; and acquisition of advanced imaging technologies to accelerate discovery. The brochure also sets out the Center’s roadmap for the future, including targeted research calls, industry partnerships, and specialized facilities for organoid growth.
SCRM—an interdisciplinary hub combining cellular therapy, translational engineering, and clinical application—was established through Sagol’s support to advance therapies and train outstanding researchers at all academic levels.
Mr. Sagol’s continued engagement underscores his commitment to fostering innovation that could transform patient care worldwide.
